Wax-it Histology Services Inc. Secures Renewal of GLP Accreditation with the Standards Council of Canada
VANCOUVER, BC (September 6th, 2024) – Wax-it Histology Services Inc., a leader in specialized histopathology and contract research, proudly announces the renewal of its Good Laboratory Practice (GLP) Accreditation by the Standards Council of Canada (SCC) on June 5th, 2024. This renewal follows a comprehensive annual inspection of the company’s state-of-the-art facilities, meticulous standard operating procedures (SOPs), and a comprehensive review of completed studies, reaffirming Wax-it’s adherence to the highest standards of laboratory excellence.
SCC accreditation represents a globally recognized mark of quality that ensures trust and credibility in the consistency, precision, and reliability of products, systems, and services. Wax-it Histology Services has upheld these demanding GLP standards since 2012 when it first achieved accreditation, underscoring its ongoing commitment to excellence in scientific research and testing. This latest renewal demonstrates Wax-it’s dedication to advancing preclinical studies with rigor, transparency, and adherence to international best practices.
For those seeking verification, a digital copy of Wax-it Histology Services’ renewed GLP accreditation is accessible via the Standards Council of Canada’s official website.
Partner with Experts: Request a Complimentary Scientific Consultation
Wax-it Histology Services offers both GLP and non-GLP support for your research needs. Connect with their experts by booking a complementary consultation through their website, www.waxitinc.com, reaching out at info@waxitinc.com or calling 604-822-1595 for your specific study requirements. Their team provides strategic guidance to optimize study design, workflow efficiency, and data integrity.
About Wax-it Histology Services Inc.
Wax-it Histology Services Inc. is a leading, privately held GLP-accredited contract research organization (CRO) known for its comprehensive histopathology and immunohistochemistry services. The company’s offerings include routine histology, advanced immunohistochemistry (IHC)/ biomarker discovery, antibody testing, resin/medical devices histopathology, brightfield & whole slide imaging, advance methods of protein analysis through western immunoblot and several other services. With expertise in both GLP and non-GLP preclinical toxicology investigations, Wax-it serves a diverse clientele, including pharmaceutical and biotechnology companies, medical device developers, academic institutions, and government agencies.
By leveraging state-of-the-art equipment and innovative methodologies, Wax-it is equipped to handle complex studies that require high-precision tissue analysis, supporting the full spectrum of drug development processes from discovery to preclinical toxicology. The company is recognized for its agility in customizing protocols to meet unique study requirements, ensuring compliance with regulatory guidelines, and accelerating timelines for clients.
For more information on Wax-it’s services, industry collaborations, and case studies, visit www.waxitinc.com.